• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov6
Viridian Therapeutics released FY2025 Q3 earnings on November 5 (EST), actual revenue USD 70.57 M (forecast USD 11.72 M), actual EPS USD -0.3444 (forecast USD -1.02)
04:00
Viridian Therapeutics released FY2025 9 Months earnings on November 5 (EST), actual revenue USD 70.72 M, actual EPS USD -2.2181
04:00
Nov5
Viridian Therapeutics Receives Buy Rating from Analyst, Drug Development Progresses Smoothly
18:56
Nov3
Viridian Therapeutics Set to Launch Veligrotug in Mid-2026
18:36
Oct21
Viridian Therapeutics Launches Public Offering of Common Stock and Non-Voting Convertible Preferred Stock
20:01
Oct20
Viridian Therapeutics Enters into Financing Agreement with DRI Healthcare and Anticipates Submitting BLA for VELIGROTUG
11:40

Schedules & Filings

Schedules
Filings
Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 70.57 M, Net Income -28.17 M, EPS -0.3444

Aug6
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 75 K, Net Income -81.98 M, EPS -1.0047

May6
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 72 K, Net Income -70.69 M, EPS -0.8689

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MNDR
3.040
+83.13%
+1.380
SOND
0.1650
+79.15%
+0.073
EPSM
3.660
+66.36%
+1.460
VSA
0.2785
+59.05%
+0.103
PACS
26.140
+55.32%
+9.310
AIIO
0.7800
+41.77%
+0.230
LUD
9.620
+39.42%
+2.720
RDACR
0.2510
+32.11%
+0.061
PLAG
2.980
+31.28%
+0.710
IONZ
6.420
+28.40%
+1.420
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy